Neurofibroma laboratory findings: Difference between revisions
Jump to navigation
Jump to search
Sara Mohsin (talk | contribs) |
Sara Mohsin (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Neurofibroma}} | {{Neurofibroma}} | ||
{{CMG}}; {{AE}} {{SC}} | {{CMG}}; {{AE}}{{S.M.}} {{SC}} | ||
==Overview== | ==Overview== | ||
[[Immunohistochemistry]] of [[neurofibroma]] shows [[Positivity effect|positivity]] for [[S100A1|S100]], [[CD34]], and factor XIIIa and [[Negativity bias|negativity]] for EMA (except in [[Plexiform neurofibroma|plexiform neurofibromas]]). | [[Immunohistochemistry]] of [[neurofibroma]] shows [[Positivity effect|positivity]] for [[S100A1|S100]], [[CD34]], and factor XIIIa and [[Negativity bias|negativity]] for EMA (except in [[Plexiform neurofibroma|plexiform neurofibromas]]). | ||
Revision as of 15:41, 25 March 2019
|
Neurofibroma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Neurofibroma laboratory findings On the Web |
|
American Roentgen Ray Society Images of Neurofibroma laboratory findings |
|
Risk calculators and risk factors for Neurofibroma laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2] Shanshan Cen, M.D. [3]
Overview
Immunohistochemistry of neurofibroma shows positivity for S100, CD34, and factor XIIIa and negativity for EMA (except in plexiform neurofibromas).
Laboratory Findings
Immunohistochemistry of neurofibroma is as follows:
- Positive for:
- Negative for:
- EMA (except in plexiform neurofibromas)